Cabrini Health Limited

Malvern, Victoria 3144

2 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumors, Advanced/Metastatic Solid Tumors, Glioma, MAPK Pathway Gene Mutation, MEK Mutation, Melanoma, NSCLC, Oncology, Ovarian Cancer, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Solid Tumor, Adult

Studies at this site

• Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors — Recruiting now
• A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — Recruiting now
• ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors — Completed
• A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed